Respicardia’s Implantable Device Benefits HF Patients With Central Sleep Apnea
Executive Summary
A phrenic nerve stimulation system from Respicardia Inc. is showing promise for the treatment of central sleep apnea, a condition commonly found in patients with heart failure.